Background: Catheter ablation as first-line therapy for ventricular tachycardia (VT) at the time
of implantable cardioverter defibrillator (ICD) implantation has not been adopted into clinical …

Twenty-five years of catheter ablation of ventricular tachycardia: a look back and a look
forward Page 1 Twenty-five years of catheter ablation of ventricular tachycardia: a look back …

Chagas disease is caused by infection from the protozoan parasite Trypanosoma cruzi.
Although it is endemic to Latin America, global migration has led to an increased incidence …

Aims Myocardial fibrosis is associated with clinical ventricular tachyarrhythmia (VTA) events
in patients with non-ischaemic dilated cardiomyopathy (DCM). Subepicardial or mid-wall …

SciELO - Brazil - Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com
Cardiomiopatia da Doença de Chagas – 2023 Diretriz da SBC sobre Diagnóstico e Tratamento …

Objectives This study sought to analyze safety and outcomes of ventricular tachycardia (VT)
substrate ablation during sinus rhythm (SR), without baseline VT induction. Background …

Background: Ablation of ventricular tachycardia (VT) in the setting of structural heart disease
often requires extensive substrate elimination that is not always achievable by endocardial …

Background Epicardial mapping and ablation are frequently necessary to eliminate
ventricular tachycardia (VT) in patients with Chagas disease. Nonetheless, there are no …

A DC (tripanossomíase americana) é entidade mórbida transmissível, potencialmente fatal,
causada pelo protozoário parasita T. cruzi e que integra o grupo de doenças tropicais …

Objectives In this study, the authors investigated the ablation success of scar
homogenization with combined (epicardial+ endocardial) vs endocardial-only approach for …